Fairvalue-Calculator Fairvalue-Calculator
EN DE

Taiwan Advance Bio-Pharmaceutical Inc (4186) Fair Value & Analysis

Healthcare · TW · Market cap 922M TWD

Price10.00 TWD
Fair Value6.16 TWD
Upside-38.4%
Quality95/100
Evidence: High Range 4.03 TWD – 7.79 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Taiwan Advance Bio-Pharmaceutical Inc (4186) currently trades at 10.00 TWD, while our model-based Fair Value estimate is 6.16 TWD — implying the stock looks roughly 38.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Taiwan Advance Bio-Pharmaceutical Inc (4186) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 6.16 TWD versus a price of 10.00 TWD — about −38% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 4186?
Our 21-model fair value for Taiwan Advance Bio-Pharmaceutical Inc is 6.16 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 10.00 TWD.
What is the quality score of 4186?
Taiwan Advance Bio-Pharmaceutical Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.